At the Emory Vaccine Center, our mission is to improve human health by conducting fundamental and clinical research that leads to the development of effective vaccines against infectious diseases of global importance.
Read More...

View the EVC Calendar of Events...

Closer Than You Know . . . to Effective AIDS Vaccines.  Raising money and awareness within Atlanta's GLBT community for the Emory Vaccine Center's HIV/AIDS vaccine research.

www.vaccines.emory.edu/closer

(Donate and get involved)

AIDS Vaccine 200
Join Team Emory for the 7th Annual Action Cycling 200 bike ride
May 16-17, 2009
www.actioncycling.org

(Riders and volunteers needed)

Charity Treks
Join us for the 2009 AIDS Vaccine Bike Trek
Burlington, VT to Portland, ME
August 11-15, 2009
www.charitytreks.org
(Riders and volunteers needed)

Minnesota AIDS Trek
23rd Annual Minnesota AIDS Trek
Twin Cities to Duluth, Minnesota
September 12-13, 2009
www.mnaidstrek.org
(Registration now open)

Emory, Australian Vaccine Centers Announce Alliance A new Queensland-US Vaccine Technology Alliance will combine the expertise of two leading vaccine research centers – the Australian Centre for Vaccine Development (ACVD) at the Queensland Institute of Medical Research and the Emory Vaccine Center (EVC) at Emory University in Atlanta.
The Alliance recently was awarded a three-year grant of $1.8M from the Smart Futures Fund of the Queensland National and International Research Alliances Program. Additional funding for the alliance will be provided by the ACVD and the EVC, with total project funding from all sources equaling $8.5M over three years.
http://www.emory.edu/home/news/releases/2009/05/emory-vaccine-center-alliance.html

Rafi Ahmed, Emory Vaccine Center Director, Elected to National Academy of Sciences
Contact:
Holly Korschun: 404.727.3990
From Woodruff Health Sciences Center News
The National Academy of Sciences (NAS) has elected Emory immunologist Rafi Ahmed, PhD, to the National Academy of Sciences. Ahmed is director of the Emory Vaccine Center, professor of microbiology and immunology in Emory University School of Medicine and a Georgia Research Alliance Eminent Scholar. He is associate director of vaccine science for the Emory Center for AIDS Research.
The NAS elected 72 new members and 18 foreign associates in recognition of their distinguished and continuing achievements in original research. Election to the NAS is one of the premier recognitions in science. Dr. Ahmed joins two other distinguished Emory faculty in the NAS, Frans de Waal and Max Cooper (also EVC faculty).
http://www.emory.edu/home/news/releases/2009/05/ahmed-elected-to-national-academy-of-sciences.html

Saad Omer, recipient of the Maurice R. Hilleman Early-stage Career Investigator Award offered by the National Foundation for Infectious Diseases (NFID)
This award was issued April 28, 2009 in Baltimore, Maryland, during the NFID’s 12th Annual Meeting on Vaccine Research. The award memorializes the lifetime achievements of Dr. Maurice R. Hilleman in the field of Vaccinology, and recognizes individuals in the early stages of their careers in Vaccinology, from basic science, through pre-clinical studies, manufacturing and production, to related research in public health, agriculture, health delivery, policy and regulatory matters.
The specific study for which Dr. Omer was recognized is entitled, “Evaluation of Combined Effects of Influenza Vaccine to Mothers and Pneumococcal Conjugate Vaccine to Infants: Results from a Randomized, Double-blind, Controlled Trial”. This was an interesting study that took advantage of the biological synergy between influenza virus and pneumococcus by evaluating the combined effect of vaccine interventions against each organism.